DK3359210T3 - Periostin-fragmenter og anvendelse deraf - Google Patents
Periostin-fragmenter og anvendelse deraf Download PDFInfo
- Publication number
- DK3359210T3 DK3359210T3 DK16778808.2T DK16778808T DK3359210T3 DK 3359210 T3 DK3359210 T3 DK 3359210T3 DK 16778808 T DK16778808 T DK 16778808T DK 3359210 T3 DK3359210 T3 DK 3359210T3
- Authority
- DK
- Denmark
- Prior art keywords
- periostin
- fragments
- periostin fragments
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/10—Musculoskeletal or connective tissue disorders
- G01N2800/108—Osteoporosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562238901P | 2015-10-08 | 2015-10-08 | |
PCT/EP2016/074086 WO2017060482A1 (en) | 2015-10-08 | 2016-10-07 | Periostin fragments and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3359210T3 true DK3359210T3 (da) | 2021-07-12 |
Family
ID=57121255
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK16778808.2T DK3359210T3 (da) | 2015-10-08 | 2016-10-07 | Periostin-fragmenter og anvendelse deraf |
Country Status (5)
Country | Link |
---|---|
US (1) | US11085932B2 (da) |
EP (1) | EP3359210B1 (da) |
DK (1) | DK3359210T3 (da) |
ES (1) | ES2885550T3 (da) |
WO (1) | WO2017060482A1 (da) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2021518387A (ja) * | 2018-03-19 | 2021-08-02 | バイオヴェンチャーズ リミテッド ライアビリティ カンパニー | ペリオスチン抗体およびその使用方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3749959B2 (ja) | 1996-02-26 | 2006-03-01 | 株式会社シノテスト | 磁性粒子を用いる被検物質の測定方法及び該方法に使用する測定器具 |
JP3762958B2 (ja) | 1996-10-25 | 2006-04-05 | 株式会社シノテスト | 粒子を用いる被検物質の測定方法及び該方法に使用する測定器具 |
SE9604378D0 (sv) | 1996-11-27 | 1996-11-27 | Tac Ab | Methods and reagents for determining protein S |
CA2457065A1 (en) * | 2001-08-13 | 2003-02-27 | Dana-Farber Cancer Institute, Inc. | Periostin-based diagnostic assays |
EP2057465A4 (en) | 2006-08-09 | 2010-04-21 | Homestead Clinical Corp | SPECIFIC ORGAN PROTEINS AND METHODS OF USE |
US20110033516A1 (en) | 2009-08-06 | 2011-02-10 | Medical University Of South Carolina | Methods and compositions for bone healing by periostin |
-
2016
- 2016-10-07 ES ES16778808T patent/ES2885550T3/es active Active
- 2016-10-07 WO PCT/EP2016/074086 patent/WO2017060482A1/en active Application Filing
- 2016-10-07 DK DK16778808.2T patent/DK3359210T3/da active
- 2016-10-07 US US15/766,489 patent/US11085932B2/en active Active
- 2016-10-07 EP EP16778808.2A patent/EP3359210B1/en active Active
Also Published As
Publication number | Publication date |
---|---|
US11085932B2 (en) | 2021-08-10 |
EP3359210B1 (en) | 2021-04-14 |
EP3359210A1 (en) | 2018-08-15 |
US20180284135A1 (en) | 2018-10-04 |
WO2017060482A1 (en) | 2017-04-13 |
ES2885550T3 (es) | 2021-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FIC20230014I1 (fi) | Foslevodopa ja foskarbidopa | |
DK3448386T3 (da) | Isoquinolin-3-ylcarboxamider og fremstilling og anvendelse deraf | |
DK3205650T3 (da) | Egfr-hæmmer og fremstilling og anvendelse deraf | |
DK3380101T3 (da) | Eif4-a-inhiberende forbindelser og fremgangsmåder relateret dertil | |
DK3368534T3 (da) | Valbenazin-ditosylat og polymorfer deraf | |
DK3151985T3 (da) | Bukkemaskine og tilsvarende fremgangsmåde | |
DK3210977T3 (da) | Hidtil ukendt aminoalkylbenzothiazepinderivat og anvendelse deraf | |
DK3610005T3 (da) | Peptidligase og anvendelse deraf | |
DK3212189T3 (da) | Substituerede chromaner og fremgangsmåde til anvendelse deraf | |
DK3354282T3 (da) | Glycan-terapeutiske midler og relaterede fremgangsmåder deraf | |
DK3313882T3 (da) | Anti-VISTA antistoffer og fragmenter | |
DK2949365T3 (da) | Gåtræningsapparat og gåtræningsfremgangsmåde deraf | |
DK3227342T3 (da) | Proteinøs heterodimer og anvendelse deraf | |
DK3201351T3 (da) | Kaloriefrie sødestoffer og fremgangsmåder til syntetisering | |
DK3155024T3 (da) | Opholdsstrukturer og relaterede fremgangsmåder | |
DK3218358T3 (da) | Ifluorometyl-aminopyridiner og difluorometyl-aminopyrimidiner | |
DK3215147T3 (da) | Neurodæmpende norketamin-forbindelser og fremgangsmåder | |
DK3015526T3 (da) | Hydrofluorolefinbaseret sammensætning og anvendelse deraf | |
DK3319611T3 (da) | Oxysteroler og fremgangsmåder til anvendelse deraf | |
DK3103046T3 (da) | Biomarkør-signaturfremgangsmåde og apparater og kits deraf | |
DK3319612T3 (da) | Oxysteroler og fremgansmåder til anvendelse derfor | |
DK3193611T3 (da) | Mk2-inhibitorer og anvendelser deraf | |
DK3256598T3 (da) | Svampestammer og anvendelsesfremgangsmåder | |
DK3265641T3 (da) | Stigørenhed og fremgangsmåde | |
DK3220750T3 (da) | Oral rehydreringssammensætning og fremgangsmåder dertil |